First Time Loading...

F-Star Therapeutics Inc
NASDAQ:FSTX

Watchlist Manager
F-Star Therapeutics Inc Logo
F-Star Therapeutics Inc
NASDAQ:FSTX
Watchlist
Price: 7.12 USD Market Closed
Updated: Jun 1, 2024

F-Star Therapeutics Inc
Net Issuance of Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

F-Star Therapeutics Inc
Net Issuance of Common Stock Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
F-Star Therapeutics Inc
NASDAQ:FSTX
Net Issuance of Common Stock
$78.3m
CAGR 3-Years
24%
CAGR 5-Years
22%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Net Issuance of Common Stock
-$1.1B
CAGR 3-Years
-9%
CAGR 5-Years
37%
CAGR 10-Years
-18%
Gilead Sciences Inc
NASDAQ:GILD
Net Issuance of Common Stock
-$719m
CAGR 3-Years
-22%
CAGR 5-Years
22%
CAGR 10-Years
-2%
Amgen Inc
NASDAQ:AMGN
Net Issuance of Common Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Issuance of Common Stock
-$288.7m
CAGR 3-Years
15%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Issuance of Common Stock
-$473.2m
CAGR 3-Years
51%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is F-Star Therapeutics Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
78.3m USD

Based on the financial report for Dec 31, 2021, F-Star Therapeutics Inc's Net Issuance of Common Stock amounts to 78.3m USD.

What is F-Star Therapeutics Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 5Y
22%

Over the last year, the Net Issuance of Common Stock growth was 422%. The average annual Net Issuance of Common Stock growth rates for F-Star Therapeutics Inc have been 24% over the past three years , 22% over the past five years .